Cargando…

Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania

Lymphatic filariasis (LF) is a neglected tropical disease targeted for elimination as public health problem through morbidity management and preventive annual mass drug administration (MDA). This cross-sectional community-based surveillance assessed the prevalence and correlates of LF infection in M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fimbo, Adam M., Minzi, Omary M.S., Mmbando, Bruno P., Barry, Abbie, Nkayamba, Alex F., Mwamwitwa, Kissa W., Malishee, Alpha, Seth, Misago D., Makunde, Williams H., Gurumurthy, Parthasarathi, Lusingu, John P.A., Kamuhabwa, Appolinary A.R., Aklillu, Eleni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290598/ https://www.ncbi.nlm.nih.gov/pubmed/32455556 http://dx.doi.org/10.3390/jcm9051550

Ejemplares similares

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study
por: Fimbo, Adam M., et al.
Publicado: (2022)

Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa—Ethiopia, Kenya, Rwanda, and Tanzania
por: Barry, Abbie, et al.
Publicado: (2021)

Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania
por: Barry, Abbie, et al.
Publicado: (2020)

Prevalence and Correlates of Asymptomatic Malaria and Anemia on First Antenatal Care Visit among Pregnant Women in Southeast, Tanzania
por: Mlugu, Eulambius M., et al.
Publicado: (2020)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
por: Khaemba, Christabel, et al.
Publicado: (2021)

Comparison of malaria treatment outcome of generic and innovator’s anti-malarial drugs containing artemether–lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children
por: Kilonzi, Manase, et al.
Publicado: (2019)

Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2020)

Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2021)

The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment
por: Maganda, Betty A, et al.
Publicado: (2015)

Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
por: Makunde, William H, et al.
Publicado: (2003)

Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2019)

Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2020)

Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
por: Kilonzi, Manase, et al.
Publicado: (2020)

Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio
por: Mlugu, Eulambius M., et al.
Publicado: (2022)

Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women
por: Mlugu, Eulambius M., et al.
Publicado: (2020)

Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women
por: Mutagonda, Ritah F., et al.
Publicado: (2016)

Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
por: Mikomangwa, Wigilya P., et al.
Publicado: (2020)

Optimal single sampling time-point for monitoring of praziquantel exposure in children
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2021)

Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region
por: Mikomangwa, Wigilya P., et al.
Publicado: (2019)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
por: Kroidl, Inge, et al.
Publicado: (2016)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
por: Kroidl, Inge, et al.
Publicado: (2016)

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women
por: Mutagonda, Ritah F., et al.
Publicado: (2017)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis
por: Chhonker, Yashpal S., et al.
Publicado: (2023)

Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study
por: Khaemba, Christabel, et al.
Publicado: (2023)

Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy
por: Maganda, Betty A, et al.
Publicado: (2014)

Safety Surveillance of Mass Praziquantel and Albendazole Co-Administration in School Children from Southern Ethiopia: An Active Cohort Event Monitoring
por: Gebreyesus, Tigist Dires, et al.
Publicado: (2022)

Recurrent Hemorrhagic Pericardial Effusion and Tamponade due to Filariasis Successfully Treated with Ivermectin and Albendazole
por: Sinha, Santosh Kumar, et al.
Publicado: (2015)

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis
por: Macfarlane, Cara L, et al.
Publicado: (2019)

Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania
por: Mwamwitwa, Kissa W., et al.
Publicado: (2022)

Lymphatic Filariasis Control in Tanzania: Effect of Repeated Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission
por: Simonsen, Paul E., et al.
Publicado: (2010)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia
por: Supali, Taniawati, et al.
Publicado: (2021)

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission
por: Simonsen, Paul E, et al.
Publicado: (2013)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India
por: Jambulingam, Purushothaman, et al.
Publicado: (2021)

Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania
por: Lupenza, Eliza, et al.
Publicado: (2021)

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
por: Laman, Moses, et al.
Publicado: (2022)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin–Diethylcarbamazine–Albendazole for Lymphatic Filariasis Elimination
por: Ghosh, Raj Shankar, et al.
Publicado: (2022)

Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study
por: Kabatende, Joseph, et al.
Publicado: (2022)

Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania
por: Lupenza, Eliza T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jjaltcjo1uccokkf9nm8m3bdtm